The OncoAlert 🚨WrapUp
DAY2⃣ #ESMO21 #EONS15
Gil Morgan, MD

Toni Choueiri, MD Neeraj Agarwal, MD, FASCO Erika Hamilton, MD Vivek Subbiah, MD Charles Swanton H. Jack West, MD Julien Mazieres John Haanen Matteo Lambertini, MD PhD Sara Tolaney Sumanta K. Pal, MD, FASCO Petros Grivas Philippe Aftimos, MD 
Kelly Mercier, Ph.D Myriam Chalabi Manju George MVSc PhD Rectal Cancer Survivor

📢 Mardi 5 octobre à 17h, ne manquez pas notre conférence live sur l' #ESMO21 !

Quelles sont les actus marquantes du congrès ? Les médecins chercheurs de Gustave Roussy les passeront en revue pour vous, spécialité par spécialité.

RDV sur ➡️youtu.be/i_-n-FuFx6I

Time flies.
With #ESMO21 data still echoing in the air, fueling discussions & algorithm changes, we’re suddenly only 10 days away from #SABCS21 !

As per tradition, here’s my personal Top 10 Abstracts to be presented at San Antonio.

Exciting new data, not to be missed! #bcsm

63,9 Monate Gesamtüberleben unter Letrozol+Ribociclib beim metastasierten Brustkrebs (HR+ Her2neu neg.) ist ein fantastisches und hoffnungsvolles Ergebnis. Monaleesa-2-Studie auf dem #ESMO21

👉 Check out the ESMO - Eur. Oncology Practicing Oncologists Working Group's new series of Spotlight presentations featuring highlights from #ESMO21

oncologypro.esmo.org/meeting-resour…

FINAL CALL: Tomorrow is the Total Health | Oncology 📖🔬 #ESMO21 special session on innovative strategies to increase clinical trial enrollment!

📆 October 23rd, 2021
🕞 3:20 PM EST

Register HERE 👉 bit.ly/3lRIvDq

Attend and earn 9.50 CME/CE credits + MOC points.
.
Join us at Total Health | Oncology 📖🔬’s #ESMO21 Review on October 23rd | 2:30 PM EST for a special session on innovative strategies to increase clinical trial enrollment!

Register HERE 👉 bit.ly/3lRIvDq

#ESMO21 trial data coverage is here!

Access it all in one place, including trials with the most Twitter reactions, with CLIN: ow.ly/wV8s50GjyzA

#OncTwitter #ClinicalTrials

Join us at Total Health | Oncology 📖🔬’s #ESMO21 Review on October 23rd/24th for an overview of the most influential data surrounding advances in oncology and clinical trial enrollment strategies. Plus, gain 9.50 CME/CE credits + MOC points!

Register HERE 👉 bit.ly/3C0OKKo

Portage is pleased to see the progress in #PD1 -based #cancer therapy presented at #ESMO21 . We look forward to sharing data from our #immunooncology clinical trials testing overcoming PD-1 resistance and augmenting PD-1 based therapy. Learn more: bit.ly/3zt5wzY

#NextGenerationSequencing #NGS in the management of #cancer by Benedikt Westphalen #ESMO21 OncoAlert VJ Oncology

Meeting old friends from Vietnam at #ESMO21 NGUYENTUANKHOI

Great Gustave Roussy post-ESMO21, to be found on YouTube ! Thanks to the master of ceremony Pr K.Fizazi. Join us for the lung session with Benjamin Besse Centre International des Cancers Thoraciques

Monotherapy for colorectal #cancer is making waves following its debut at #ESMO21 . Check it out now: bit.ly/3oQjoAZ #Oncology #MedEd

After #ESMO21 presentation, BrighTNess trial 4y survival is out on Annals of Oncology

Among 634 pts with TNBC, the addition of carboplatin to neoadjuvant AC-T significantly improved EFS, with no improvement in OS

Adding veliparib did not improve outcomes

annalsofoncology.org/article/S0923-…

ONCODEBATES PRESENCIAL estudios presentados en #ESMO21 Antonia Perelló presentará para discusión Keynote 522 y 355. Esta pembrolizumab aprobado en C Mama triple negativo avanzado o en estadios iniciales? las pacientes deben cumplir algunos criterios indispensables? SOLTI #cancerresearch SEOM

Clear diagram about #biomarker testing by #NGS from Javier Hernandez Losa at #ESMO21

Clearly the molecular pathologist has a central role but also clearly shows the participation of the multidisciplinary team needed #genomics #bioinformatics #tumourboard OncoAlert VJ Oncology

Now time for the discussion of CM816 & KN671 abstracts Jarushka Naidoo is nailing it! Academic, accurate, balanced 👌
#ESMO21 #LCSM ESMO - Eur. Oncology Women4Oncology

Dr. Heather Wakelee presented this data at #ASCO21 and updated by Enriqueta Felip ESMERALDA

#LCSM #LCSM Chat

Destiny-Breast 03. Previously at #ESMO21 but now in #NEJM .
Great step for pts with mBC but also for all of us! Congrats to all investigators, specially to ⁦Javier Cortes MD PhD⁩ 👏👏👏
Thanks! Today, Oncology is more beautiful, interesting and hopeful.
nejm.org/doi/full/10.10…